{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:09:16Z","timestamp":1769846956893,"version":"3.49.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Science and Technology Funding of Tianjin Chest Hospital","award":["2018XKZ07"],"award-info":[{"award-number":["2018XKZ07"]}]},{"name":"Tianjin Health Science and Technology project","award":["MS20016"],"award-info":[{"award-number":["MS20016"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The efficacy and safety of bivalirudin in percutaneous coronary intervention (PCI) has always been a hot topic in perioperative antithrombotic therapy, but there are still some controversies. So studies are needed to provide more evidence, especially the real world study which includes patients excluded from previous RCT studys. Our study aimed to investigate these information and analyze the independent predictors of postoperative adverse events.<\/jats:p>\n            <jats:p>A retrospective study enrolled 1416 patients underwent PCI in Tianjin Chest Hospital from May 2016 to October 2017. The incidence of stent-thrombosis and net clinical adverse events, including all-cause death, myocardial infarction, stroke, urgent target-vessel revascularization and bleeding, were followed up for 30\u200adays and 1\u200ayear. Logistic regression and COX regression were respectively used to analyze independent predictors of bleeding events within 30-days, and independent predictors of Major adverse cardiovascular and cerebrovascular events (MACCE) in patients with stent implantation within 1-year.<\/jats:p>\n            <jats:p>Seven hundred six patients were treated with bivalirudin while 710 with unfractionated heparin (UFH). The proportions of diabetes, hypertension, anemia, myocardial-infarction history, PCI history, moderate-to-severe renal-impairment, gastrointestinal-bleeding history in the bivalirudin group were significantly higher (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Women, anemia were independent risk factors for bleeding within 30-days (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Among 682 patients with stent implantation in bivalirudin group, anemia, Body Mass Index (BMI) &gt;25\u200akg\/m<jats:sup>2<\/jats:sup>, KILLIP \u22652, ejection fraction (EF) &lt;45%, eGFR &lt;60\u200aml\/minutes were independent risk factors for MACCE, while Statins, proton pump inhibitor (PPI) were independent protective factors for MACCE with-in 1-year (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05).<\/jats:p>\n            <jats:p>Bivalirudin have good anticoagulant effect and lower bleeding risk during PCI, especially in patients with higher bleeding risk. In patients treated with bivalirudin, female, anemia were independent predictors of bleeding within 30-days, BMI &gt;25\u200akg\/m<jats:sup>2<\/jats:sup>, anemia, KILLIP \u22652, EF &lt;45%, eGFR &lt;60\u200aml\/minutes were independent risk factors and Statins, PPI were independent protective factors of MACCE within 1-year.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025003","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:00:35Z","timestamp":1615510835000},"page":"e25003","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5956-8579","authenticated-orcid":false,"given":"Yue-cheng","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-jie","family":"Yao","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-xia","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-xia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-han","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-liang","family":"Cong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Chest Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1016\/j.thromres.2011.12.026","article-title":"Thrombosis and acute coronary syndrome","volume":"129","author":"Abbate","year":"2012","journal-title":"Thrombosis Res"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamacardio.2016.2049","article-title":"Updates on acute coronary syndrome: a review","volume":"1","author":"Eisen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial","volume":"313","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","article-title":"Bivalirudin or unfractionated heparin in acute coronary syndromes","volume":"373","author":"Valgimigli","year":"2015","journal-title":"New Eng J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018\u200aESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5603\/KP.2018.0203","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"76","author":"Thygesen","year":"2018","journal-title":"Kardiol Pol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati","year":"2008","journal-title":"New Eng J Med"},{"issue":"(4)","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjcard.2012.04.017","article-title":"Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention from the anti-thrombotic strategy for reduction of myocardial damage during angioplasty\u2013bivalirudin vs heparin study","volume":"110","author":"Patti","year":"2012","journal-title":"Am J Cardiol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1062-1458(03)00187-9","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention","volume":"12","author":"Lincoff","year":"2003","journal-title":"ACC Current J Rev"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management one-year results from the ACUITY trial","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"N Engl J Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2016.04.140","article-title":"Bivalirudin versus unfractionated heparin for percutaneous coronary intervention with radial access: a meta-analysis of randomized trials","volume":"216","author":"Mahmoud","year":"2016","journal-title":"Int J Cardiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.recesp.2016.01.036","article-title":"Bivalirudin versus unfractionated heparin in acute coronary syndromes: an updated meta-analysis of randomized trials","volume":"69","author":"Verdoia","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2016.01.206","article-title":"Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"209","author":"Zhang","year":"2016","journal-title":"Int J Cardiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1055\/s-0038-1673687","article-title":"Determinants of significant out-of-hospital bleeding in patients undergoing percutaneous coronary intervention","volume":"118","author":"Sorrentino","year":"2018","journal-title":"Thromb Haemost"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.119.041619","article-title":"Long-term safety and efficacy of durable polymer cobalt-chromium everolimus-eluting stents in patients at high bleeding risk","volume":"141","author":"Sabato","year":"2020","journal-title":"Circulation"},{"key":"R20-20250504","first-page":"365","article-title":"Predictors of clinically significant bleeding events in bivalirudin-treated Chinese patients with acute myocardial infarction undergoing percutaneous coronary intervention","volume":"97","author":"Wang","year":"2017","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjcard.2015.10.029","article-title":"Impact of bleeding and bivalirudin therapy on mortality risk in women undergoing percutaneous coronary intervention from the REPLACE-2, ACUITY, and HORIZONS-AMI trials","volume":"117","author":"Ng","year":"2016","journal-title":"Am J Cardiol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ahj.2008.12.003","article-title":"Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes","volume":"157","author":"Tiz\u00f3n-Marcos","year":"2009","journal-title":"Am Heart J"},{"key":"R23-20250504","first-page":"688","article-title":"Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention","volume":"26","author":"Nie","year":"2006","journal-title":"Chin J Pract Internal Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0735-1097(97)00064-8","article-title":"A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study","volume":"29","author":"Kiemeneij","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0003319713488931","article-title":"Anxiety score as a risk factor for radial artery vasospasm during radial interventions: a pilot study","volume":"65","author":"Ercan","year":"2014","journal-title":"Angiology"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejim.2018.12.004","article-title":"Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome","volume":"61","author":"Vicente-Ibarra","year":"2019","journal-title":"Eur J Intern Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.amjcard.2014.09.023","article-title":"Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes from the acute catheterization and urgent intervention triage strategy trial","volume":"114","author":"Kunadian","year":"2014","journal-title":"Am J Cardiol"},{"key":"R28-20250504","first-page":"2041","article-title":"Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: a system review and meta-analysis","volume":"7","author":"Wang","year":"2015","journal-title":"J Thorac Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00392-011-0361-9","article-title":"In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty","volume":"101","author":"D\u00fcndar","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"e003279","DOI":"10.1161\/CIRCINTERVENTIONS.115.003279","article-title":"Blood transfusion and the risk of acute kidney injury among patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"9","author":"Karrowni","year":"2016","journal-title":"Circulation Cardiovascular Interv"},{"key":"R31-20250504","first-page":"150","article-title":"Association between chronic kidney dysfunction and coronary artery calcification score in elderly patients","volume":"33","author":"Yan","year":"2014","journal-title":"Chin J Geriatr"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11897-016-0308-6","article-title":"Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications","volume":"13","author":"Kim","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1540-8183.2011.00698.x","article-title":"Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary intervention","volume":"25","author":"Savic","year":"2012","journal-title":"J Interv Cardiol"},{"key":"R34-20250504","first-page":"121","article-title":"Impact of body mass index on clinical outcomes in patients undergoing coronary revascularization","volume":"15","author":"Kang","year":"2007","journal-title":"Chin J Interv Cardiol"},{"key":"R35-20250504","first-page":"1537","article-title":"Metabolic syndrome may be better at predicating the prognosis of coronary artery disease than other traditional cardiovascular risk factors","volume":"90","author":"Hu","year":"2010","journal-title":"Natl Med J China"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1755-5922.2011.00302.x","article-title":"Do statins have a role in reduction\/prevention of post-PCI restenosis?","volume":"31","author":"Prasad","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MCG.0b013e3181faec3c","article-title":"Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel","volume":"45","author":"Alli","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:02:34Z","timestamp":1746338554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025003"}},"subtitle":["A real world retrospective study"],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025003","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"2020-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}